cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent Protein Kinase, more commonly called Protein Kinase A (PKA), which transduces the signal through phosphorylation of different target proteins. The inactive holoenzyme of PKA is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits of PKA have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. It may interact with various A-kinase anchoring proteins (AKAPs) and determine the subcellular localization of PKA. This subunit has been shown to regulate protein transport from endosomes to the Golgi apparatus and further to the endoplasmic reticulum (ER).[6]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Taskén K, Naylor SL, Solberg R, Jahnsen T (Jun 1998). "Mapping of the gene encoding the regulatory subunit RII alpha of cAMP-dependent protein kinase (locus PRKAR2A) to human chromosome region 3p21.3-p21.2". Genomics. 50 (3): 378–81. doi:10.1006/geno.1998.5326. PMID9676433.
^Herberg FW, Maleszka A, Eide T, Vossebein L, Tasken K (Apr 2000). "Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding". Journal of Molecular Biology. 298 (2): 329–39. doi:10.1006/jmbi.2000.3662. PMID10764601.
^Kapiloff MS, Schillace RV, Westphal AM, Scott JD (Aug 1999). "mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes". Journal of Cell Science. 112 (16): 2725–36. doi:10.1242/jcs.112.16.2725. PMID10413680.
Harrich D, McMillan N, Munoz L, Apolloni A, Meredith L (Dec 2006). "Will diverse Tat interactions lead to novel antiretroviral drug targets?". Current Drug Targets. 7 (12): 1595–606. doi:10.2174/138945006779025338. PMID17168834.
Obar RA, Dingus J, Bayley H, Vallee RB (Nov 1989). "The RII subunit of cAMP-dependent protein kinase binds to a common amino-terminal domain in microtubule-associated proteins 2A, 2B, and 2C". Neuron. 3 (5): 639–45. doi:10.1016/0896-6273(89)90274-2. PMID2561973. S2CID1329548.
Rubino HM, Dammerman M, Shafit-Zagardo B, Erlichman J (Nov 1989). "Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2". Neuron. 3 (5): 631–8. doi:10.1016/0896-6273(89)90273-0. PMID2701845. S2CID45499202.
Pariset C, Weinman S (Dec 1994). "Differential localization of two isoforms of the regulatory subunit RII alpha of cAMP-dependent protein kinase in human sperm: biochemical and cytochemical study". Molecular Reproduction and Development. 39 (4): 415–22. doi:10.1002/mrd.1080390410. PMID7893490. S2CID36203256.
Hofmann B, Nishanian P, Fan J, Nguyen T, Fahey JL (Jul 1994). "HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro". AIDS. 8 (7): 1016–7. doi:10.1097/00002030-199407000-00025. PMID7946090.
Beebe SJ, Salomonsky P, Holroyd C, Becker D (Dec 1993). "Differential expression of cyclic AMP-dependent protein kinase isozymes in normal human melanocytes and malignant melanomas". Cell Growth & Differentiation. 4 (12): 1005–12. PMID8117614.
Foss KB, Solberg R, Simard J, Myklebust F, Hansson V, Jahnsen T, Taskén K (Jan 1997). "Molecular cloning, upstream sequence and promoter studies of the human gene for the regulatory subunit RII alpha of cAMP-dependent protein kinase". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1350 (1): 98–108. doi:10.1016/S0167-4781(96)00152-2. PMID9003463.